Connect with us

business

Organigram Files Judicial Review of Health Canada’s Extract-Edible Decision  – Cannabis | Weed | Marijuana

Published

on


Organigram has launched a judicial review of Health Canada‘s extract-edible decision. On March 31st, 2023, the licensed producer filed a notice of application with the Federal Court of Canada for Judicial Review.

As a spokesperson for Organigram told CLN, “We remain of the view that the patent pending products are properly classified as cannabis extracts and compliant with the Cannabis Regulations.”

Organigram Files Judicial Review 

Organigram Judicial Review

Earlier this year, Health Canada caught the already fledgling Canadian cannabis industry by surprise when they announced certain products were dangerous.

Although “dangerous” wasn’t a word they used, we must infer it from their alleged commitment to public health and safety.

Suppose Organigram’s Edison Jolts are actually “edible cannabis products erroneously being classified and marketed as cannabis extract products,” as Health Canada told CLN. In that case, there is a clear and present danger to Canadian cannabis consumers. 

Except, there isn’t. 

Whether something is a “chewable extract” or an “edible” is irrelevant. Consumers bought Edison Jolts based on THC content, price, and availability. The only “public health and public safety risks” are the fantasies conjured by federal bureaucrats.

Organigram told CLN they launched Edison Jolts after “significant research, development and regulatory work.”

While the LP couldn’t provide additional details, there must be enough to warrant a Judicial Review in Federal Court, which is now underway.

What is a Judicial Review?

Organigram Judicial Review

Some bureaucrats, like those in the Canadian territory of the Yukon, believe they are above the law. That trained legal professionals should defer their expertise to government midwits.

But centuries of legal tradition beg to differ.

The Notice of Application that Organigram filed sets the grounds for the legal challenge. It likely outlines Health Canada’s alleged errors while requesting the Federal Court to review the decision and reconsider the ordinance.

Judicial review is a power the Federal Court has to review (and disregard if necessary) the various rules and regulations of regulatory bodies, tribunals, and government departments.

The idea behind a judicial review is to ensure these agencies act within the confines of their authority, procedural fairness, and the rule of law.

And indeed, if the Federal Court’s Judicial Review agrees with Organigram, it wouldn’t be the first time Health Canada overstepped their legal bounds.

For example, Health Canada approved dangerous pesticides for use in food production. An advocacy group challenged them, and the Federal Court agreed. Health Canada needs to reconsider their decision.

Or consider a pharmaceutical for a rare genetic disorder. Health Canada said it was good to go. The Federal Court said, you better check again.

Federal Court documents are public (unless there’s a Confidentiality Order). Because of this, Canadians could see how the Trudeau government based its covid travel restrictions on politics rather than science.

While monopolistic courts of ultimate-decision making aren’t immune from criticism, they retain a powerful balance against the petty tyranny of Western bureaucrats and politicians. Organigram having to file a judicial review over cannabis products people are voluntarily buying is a perfect example.

Do We Need Health Canada?

Organigram Judicial Review

Organigram is filing a request for judicial review concerning Health Canada’s extract-edible decision.

Which begs the question: do we even need Health Canada?

The famous Chinese philosopher Lao Tzu once said, “The more laws and order are made prominent, the more thieves and robbers there will be.”

And that’s undoubtedly true in cannabis, where the people who once threw you in a cage for it are now profiting from it and helping write the rules.

But the cannabis industry – or any industry, for that matter – doesn’t require these large, extensive bureaucracies. We already have laws on the books to regulate goods and services.

Tort and criminal law provide security, while contract, property, and commercial law facilitate cooperation and exchange. Politicians don’t need to get involved.

We need rules and regulations to live together peacefully. But with the freedom to fail, succeed, take risks, and act on opportunities.

The Western legal tradition of common law promotes rules and regulations that minimally infringe on civil and economic liberties.

The rules and regulations created and imposed by the centralized state allow specific individuals to exercise political power over others. It masks the exploitative actions of Health Canada under the guise of “public health and safety.”

But as Organigram is finding out, Health Canada’s definition of words changes depending on how they feel.

A better system would place accreditation and regulatory agencies in a free market where a third party guarantees your cannabis. And where that third party’s reputation relies on approving quality.

Health Canada approved a dangerous pesticide for use on food crops. The decision required a federal judge to intervene. If Health Canada was a private accreditation company, given this history, would you trust them with regulating cannabis?

If there’s any lesson in Organigram filing for a judicial review, it’s this.





Source link

business

Marijuana rescheduling leaves regulators and sellers cautiously optimistic

Published

on

By



A move by the Biden Administration to change how marijuana is treated by federal authorities was met with cautious approval by Massachusetts state regulators, cannabis sellers, and national marijuana advocates alike.

The Drug Enforcement Agency will drop marijuana from the list of banned substances found under Schedule I of the Controlled Substances Act, where it currently sits alongside heroin and LSD. It will instead move it to Schedule III, among the likes of Tylenol with codeine and anabolic steroids. This follows the recommendation of the Department of Health and Human Services

“Rescheduling cannabis is a monumental step forward for the federal government, one that can open new avenues to research, medical use, and banking for the regulated industries states like Massachusetts have built across the country,” said Ava Callender Concepcion, the acting chair of the Bay State’s Cannabis Control Commission.

Read the rest of this story on BostonHerald.com.



Source link

Continue Reading

business

Thailand Considers Relisting Cannabis as a Narcotic

Published

on

By


The Thai government is contemplating the relisting of cannabis as a narcotic due to concerns over its recreational use and potential societal harms. This reconsideration comes after cannabis was decriminalized in June 2022, which led to a surge in its availability and use.

Cannabis Conundrum: Thailand Reconsiders Legal Status Amidst Rising Concerns

The recent decriminalization of cannabis in Thailand has ignited a complex debate over its legal status and societal impact. While the policy aimed to boost the medical marijuana industry and provide economic opportunities, the unintended rise in recreational use has sparked discussions about a potential reclassification.

Public Health Minister Anutin Charnvirakul, a key advocate for the decriminalization, emphasized that the policy was intended to promote medical use, not recreational. However, the current legal framework lacks clear regulations governing recreational use, leading to widespread availability and potential misuse.

The Bhumjaithai Party, led by Anutin, initially pushed for the delisting of cannabis to benefit the medical industry and provide economic opportunities for Thai citizens. However, the subsequent surge in recreational use, particularly among youths, has raised concerns about potential health and social consequences.

Opposition parties have criticized the government for inadequate regulations and are advocating for cannabis to be relisted as a narcotic under the Narcotics Act. They argue that the current situation exposes young people to potential harm and lacks sufficient safeguards.

A recent poll revealed that a majority of Thais support stricter regulations on cannabis use. Concerns have been raised about the potential impact on public health, particularly regarding mental health issues and addiction, especially among youths. Additionally, there are worries about the potential for increased crime and social disorder.

The government now faces the challenge of balancing the economic benefits of a burgeoning cannabis industry with the need to protect public health and safety. Finding a solution that addresses the concerns of both advocates and critics will be crucial in determining the future of cannabis in Thailand

Why It Matters

Thailand’s shift in cannabis policy has garnered international attention, serving as a case study for the complexities of drug policy reform. The potential reclassification of cannabis underscores the challenges of balancing economic opportunities with public health and safety considerations. The outcome of this debate will have significant implications for Thailand’s legal landscape, public health policies, and the future of its cannabis industry.

Potential Implications of Relisting Cannabis as a Narcotic

If cannabis is relisted as a narcotic, it could lead to stricter regulations on its cultivation, distribution, and use. This may impact the growth of the medical marijuana industry and limit access for patients who rely on cannabis for therapeutic purposes. Additionally, it could result in increased criminal penalties for possession and use, potentially leading to a rise in incarceration rates.

Alternatively, if the government opts to maintain the decriminalized status, it will need to implement robust regulations and public health campaigns to mitigate the risks associated with recreational use. This includes age restrictions, educational initiatives, and support systems for individuals struggling with cannabis dependence.

The Bigger Picture

The debate surrounding cannabis legalization and regulation is a global phenomenon, with countries around the world grappling with similar challenges. The Thai government’s decision regarding cannabis will likely be influenced by international trends and best practices in drug policy reform. It is crucial to consider the experiences of other nations that have legalized or decriminalized cannabis, examining both the successes and challenges they have encountered.

Source: Thai PBS World



Source link

Continue Reading

banking

“A big deal”: What the feds’ move to reclassify marijuana means for Colorado cannabis

Published

on

By



Cannabis advocates in Colorado cheered the Biden Administration’s reported move to reclassify marijuana and said the decision likely would reduce businesses’ tax burden significantly.

Industry leaders cautioned that such a move — if finalized — would not resolve some major challenges facing the industry, such as limited access to banking. But they pointed to the symbolic importance of preparations by the U.S. Drug Enforcement Administration to downgrade the substance’s drug classification.

A man pours cannabis into rolling papers as he prepares to roll a joint the Mile High 420 Festival in Civic Center Park in Denver, April 20, 2024. (Photo by Kevin Mohatt/Special to The Denver Post)

Read the rest of this story on DenverPost.com.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media